All Stories

Spero halts development on another antibiotic in latest reprioritization

Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to also strip away its remaining pipeline.

Mar 28, 2025 - 12:08
 0
Spero halts development on another antibiotic in latest reprioritization
Having stripped back its workforce, antibiotics biotech Spero Therapeutics continues to also strip away its remaining pipeline.
Read More

Tags:

Previous Article

5 minutes with ... Opteven UK chief executive Ludovic Troyes

Next Article

Estée Lauder UK and Ireland swings to loss, one-offs mainly to blame but sales d...

Related Posts

Otsuka breaks up with cancer candidates on strategic grounds

Otsuka breaks up with cancer candidates on strategic gr...

Feb 14, 2025  0

Fierce Biotech Layoff Tracker 2025: Elevation eliminates 70% of staff; bit.bio cuts 25% of workforce

Fierce Biotech Layoff Tracker 2025: Elevation eliminate...

Mar 20, 2025  0

Takeda's $300M bet on Protagonist's blood cancer drug pays off with phase 3 win

Takeda's $300M bet on Protagonist's blood cancer drug p...

Mar 3, 2025  0